Kalvista Pharmaceuticals Inc (KALV)

Sales/Maturities of Investments

-$22.53M

Quarterly · Period ending: · USD

KALV logo

KALV Sales/Maturities of Investments

Latest reported-$22.53M
KALV Quarterly Sales/Maturities of Investments ($0.00 → -$22.53M)
High-resolution chart · PNG

KALV sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kalvista Pharmaceuticals Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
-22,525,000
15,730,000
0
41,677,000
21,177,000
15,207,000
48,876,000
38,230,000
15,480,000
11,558,000
32,531,000
45,386,000
28,348,000
51,153,000
20,290,000
41,066,000
65,025,000
45,824,000
50,658,000
34,204,000
7,946,000
14,431,000
15,919,000
15,342,000
14,718,000
12,323,000
21,515,000
18,214,000
10,698,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.